Matthias Alder - 23 Dec 2021 Form 4 Insider Report for Gain Therapeutics, Inc. (GANX)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Matthias Alder
Issuer symbol
GANX
Transactions as of
23 Dec 2021
Transactions value $
$1,172,000
Form type
4
Filing time
28 Dec 2021, 15:30:21 UTC
Next filing
19 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GANX Non Qualified Stock Option (right to buy) Award $1,172,000 +200,000 $5.86 200,000 23 Dec 2021 Common Stock 200,000 $5.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50,000 options shall vest on 10/15/2022 (the "Initial Vesting Date") and the remaining 150,000 options shall vest in a series of thirty-six (36) successive equal monthly installments on each subsequent monthly anniversary of the Initial Vesting Date.